Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»Cannabis and Chronic Nerve Pain: The Results Aren’t What Many Expect
    Health

    Cannabis and Chronic Nerve Pain: The Results Aren’t What Many Expect

    By CochraneJanuary 25, 20264 Comments3 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Trigeminal Neuralgia Severe Facial Nerve Pain
    Cannabis-based medicines are often seen as a promising option for people living with chronic nerve pain, especially when standard treatments fail. But a major evidence review tells a far more cautious story. Credit: Shutterstock

    A comprehensive review of clinical trials finds little convincing evidence that cannabis-based medicines provide real relief for chronic nerve pain.

    An updated Cochrane review reports that there is still no clear evidence showing cannabis-based medicines provide meaningful relief for people with chronic neuropathic pain. Despite growing interest in these treatments, the available research does not support their effectiveness compared with a placebo.

    Why Patients With Nerve Pain Look for Alternatives

    Chronic neuropathic pain develops as a result of nerve damage and is often difficult to manage. Standard medications offer significant relief to only a small share of patients, which has increased interest in alternative approaches such as cannabis-based medicines. These treatments may include herbal cannabis or specific compounds taken from the plant, such as tetrahydrocannabinol (THC), and are delivered through inhalation, mouth sprays, tablets, creams, or patches applied to the skin.

    How the Evidence Was Reviewed

    To evaluate whether these treatments work, researchers analyzed 21 clinical trials involving more than 2,100 adults. In each study, cannabis-based medicines were compared with placebo treatments over periods ranging from two to 26 weeks.

    The products examined fell into three main categories. Some contained mostly THC, the psychoactive compound in cannabis. Others were primarily made up of cannabidiol (CBD), a compound that does not cause intoxication. A third group included products with roughly equal amounts of THC and CBD.

    Findings Show Limited Benefit Over Placebo

    Across all three categories, the review found no high-quality evidence that cannabis-based medicines reduced neuropathic pain more effectively than placebo. Although some patients using products that combined THC and CBD reported small improvements, these changes were not large enough to be considered clinically meaningful.

    Side Effects and Gaps in Safety Data

    The reporting of side effects varied widely between trials, which limited confidence in the safety findings. Overall certainty about adverse effects was rated as low to very low for all types of cannabis-based medicines. Products containing THC were linked to higher rates of symptoms such as dizziness and drowsiness, along with a possible increase in the number of participants who stopped treatment because of side effects.

    Researchers Call for Better Quality Studies

    “We need larger, well-designed studies with a treatment duration of at least 12 weeks that include people with comorbid physical illnesses and mental health conditions to fully understand the benefits and harms of cannabis-based medicines,” said Winfried Häuser, clinician and lead author, from Technische Universität München and Medical Center Pain Medicine and Mental Health Saarbrücken. “At present, the quality of most of the trials is too poor to draw firm conclusions.”

    The authors conclude that the current evidence remains weak and uncertain, highlighting the need for higher-quality research before cannabis-based medicines can be recommended for chronic neuropathic pain.

    Reference: “Cannabis‐based medicines for chronic neuropathic pain in adults” by Gülay Ateş, Patrick Welsch, Petra Klose, Tudor Phillips, Britta Lambers, Winfried Häuser and Lukas Radbruch, 19 January 2026, Cochrane Database of Systematic Reviews.
    DOI: 10.1002/14651858.CD012182.pub3

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Cannabis Chronic Pain Cochrane
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    One Year of Medicinal Cannabis: Real-World Relief for Pain, Sleep, and Mental Health

    Scientists Just Found a THC-Free Cannabis Compound That May Replace Opioids

    A Waste of Money: New Study Reveals That CBD Is Ineffective for Pain Relief

    Nature’s Painkiller: Natural Molecules Found in Cannabis Rival Morphine in Groundbreaking Study

    Medicinal Cannabis Reduces Pain and Need for Opiate Painkillers Among Cancer Patients

    New Research Shows Pain Relieving Effects of CBD

    Doctors Still Reluctant to Prescribe Medical Cannabis for Pain Relief

    More Than 90% of Legal Marijuana Products Too Strong for Chronic Pain Relief

    Greater Risk for Cannabis Use Disorder Among Adults With Chronic Pain

    4 Comments

    1. Tom McCarthy on January 26, 2026 5:14 am

      Not a doctor or a pain management specialist, just a guy with severe bilateral foot neuropathy post-trauma and surgery.

      Medical THC as a tincture with drops under my tongue has allowed me to once again walk the golf course without being in misery.

      My marathon days are over, but I can still enjoy life, so from my point of view, the experts don’t know diddly.

      Reply
    2. Eric M. Jones on January 27, 2026 7:05 am

      Yes, but the “experts” are funded by anti-marijuana forces like alcohol distillers. This has never been so clear.
      As for “damage,” compare MJ to alcohol.

      (I don’t drink or use drugs or MJ.)

      Reply
      • Bree on January 27, 2026 3:07 pm

        I think, you hit the nail on the head.
        Believe nothing they tell you, or do the opposite!

        Reply
    3. Buck on January 28, 2026 6:52 am

      Brought to you by big pharma..A natural plant is bad, but our manufactured pill is the answer..remember when they told you OxyContin was the wonder drug for pain and not addictive..

      Reply
    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    The Universe Is Expanding Too Fast and Scientists Can’t Explain Why

    “Like Liquid Metal”: Scientists Create Strange Shape-Shifting Material

    Early Warning Signals of Esophageal Cancer May Be Hiding in Plain Sight

    Common Blood Pressure Drug Shows Surprising Power Against Deadly Antibiotic-Resistant Superbug

    Scientists Uncover Dangerous Connection Between Serotonin and Heart Valve Disease

    Scientists Discover a “Protector” Protein That Could Help Reverse Hair Loss

    Bone-Strengthening Discovery Could Reverse Osteoporosis

    Scientists Uncover Hidden Trigger Behind Stem Cell Aging

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Scientists Crack Alfalfa’s Chromosome Mystery After Decades of Debate
    • Ancient Ant-Plant Alliance Collapses As Predatory Wasps Move In
    • Scientists Discover Tiny New Spider That Hunts Prey 6x Its Size
    • Natural Component From Licorice Shows Promise for Treating Inflammatory Bowel Disease
    • New Research Finds Shocking Link Between Chili Peppers and Cancer
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.